BTL.SG - BT Group plc
| Previous Close | 73.88 |
| Open | 73.64 |
| Bid | 74.10 x 200000 |
| Ask | 74.68 x 200000 |
| Day's Range | 73.55 - 74.14 |
| 52 Week Range | 54.64 - 81.15 |
| Volume | 20 |
| Avg. Volume | 26 |
| Market Cap | 735.287B |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Barrons.com
Citigroup and 23 More Dividend Stocks That Offer Shelter in a Slowing Economy
Now that the U.S. economy is expanding less quickly, stocks with the fastest and most sustainable dividend growth are worth considering, according to a recent research note by UBS.
- Business Wire
Baxter to Present at the 38th Annual J.P. Morgan Healthcare Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present on Monday, January 13, 2020 at 10:00 a.m. Pacific Time.
- Newsfile
Baxter Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Baxter International, Inc. To Contact The Firm
New York, New York--(Newsfile Corp. - December 4, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Baxter International, Inc. (NYSE: BAX) ("Baxter" or the "Company") of the January 24, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi logoIf you invested in Baxter stock or options between February 21, 2019 ...
- Insider Monkey
Hedge Funds Are Dumping Baxter International Inc. (BAX)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Hedge funds' top 3 stock picks returned 41.7% this year and beat […]
- PR Newswire
ROSEN, A HIGHLY RANKED FIRM, Announces Filing of Securities Class Action Lawsuit Against Baxter International Inc. - BAX
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Baxter International Inc. (NYSE: BAX) between February 21, 2019 and October 23, 2019, inclusive (the "Class Period"). The lawsuit seeks to recover damages for Baxter investors under the federal securities laws.
- PR Newswire
INVESTOR ALERT - Baxter International Inc. (BAX) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: January 24, 2020
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Baxter International Inc. ("Baxter" or the "Company") (NYSE: BAX) and certain of its officers, on behalf of shareholders who purchased Baxter securities between February 21, 2019 and October 23, 2019, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/bax.
- PR Newswire
Hagens Berman, NATIONAL TRIAL ATTORNEYS, Encourages Baxter International (BAX) Investors with $100k+ Losses to Contact its Attorneys, Securities Fraud Lawsuit Filed Concerning Admitted Improper Accounting
Hagens Berman urges Baxter International (NYSE: BAX) investors who have suffered losses in excess of $100,000 to submit their losses now to learn if they qualify to recover compensable damages. A securities fraud class action has been filed against the Company and senior executives.
- TEST Business Wire Releases
ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Baxter International Inc. – BAX
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Baxter International Inc. (NYSE: BAX) between February 21, 2019 and October 23, 2019, inclusive (the "Class Period"). The lawsuit seeks to recover damages for Baxter investors under the federal securities laws.
- TEST Business Wire Releases
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Baxter International Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Baxter International Inc.
- TEST Business Wire Releases
BAXTER INTERNATIONAL ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Baxter International, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, announces that a class action lawsuit has been filed in the United States District Court for the Northern District of Illinois on behalf of investors that purchased Baxter International, Inc. (NYSE: BAX) securities between February 21, 2019 and October 23, 2019 (the "Class Period"). Investors have until January 24, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- PR Newswire
Kessler Topaz Meltzer & Check, LLP Files A Shareholder Class Action Lawsuit Against Baxter International Inc. For Violations Of Federal Securities Laws
The law firm of Kessler Topaz Meltzer & Check, LLP announces that the firm has filed a securities fraud class action lawsuit against Baxter International Inc. (NYSE: BAX) ("Baxter") on behalf investors who purchased or otherwise acquired Baxter common stock between February 21, 2019 and October 23, 2019, inclusive (the "Class Period"). This action, captioned Ethan E. Silverman v. Baxter International Inc., et al., Case No. 1:19-cv-07786, was filed in the United States District Court for the Northern District of Illinois.
- TEST Business Wire Releases
ROSEN, A GLOBAL LAW FIRM, Continues its Investigation of Securities Claims Against Baxter International Inc. – BAX
Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Baxter International Inc. (NYSE: BAX), resulting from allegations that Baxter may have issued materially misleading business information to the investing public.
- Insider Monkey
Oakmark Funds On Humana, Baxter International and News Corp
Oakmark Funds released its 2019 Q3 letter to investors giving its commentary on a number of its positions, highlighting the investment strategy and stock picks for the quarter- download a copy here. The investment management company did not have a good quarter, losing 2.1%, while the S&P 500 gained 1.7%. For the fiscal year ending September 30, […]
- Simply Wall St.
Is Baxter International Inc. (NYSE:BAX) A High Quality Stock To Own?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
- Investor's Business Daily
Medtech Giant Unveils Accounting Probe And Sacrifices Its Flat Base
Baxter stock plunged to a four-month low in heavy volume Thursday after the medical technology firm announced an accounting investigation that overshadowed a relatively strong third quarter.
- GuruFocus.com
Dow Stocks Decline on Negative Economic Data
Hershey shares fall despite posting earnings beat Continue reading...
- MarketWatch
UPDATE: Medical products maker Baxter launches probe of misstatements in non-operating income, stock slides
Medical products company Baxter International Inc. said Thursday it has launched an investigation of misstatements in previously reported non-operating income related to foreign exchange gains and losses. Deerfield, Ill.-based Baxter said the investigation involves intra-company transactions undertaken for the purpose of generating forex gains and losses, that used a forex rate convention that did not comply with Generally Accepted Accounting Principles, or GAAP, the U.S. accounting standard. The result was certain misstatements in numbers reported in the period stretching from 2014 through the first half of 2019. The company's audit committee is overseeing the probe with the help of independent external advisers. The company has voluntarily disclosed the probe to the Securities and Exchange Commission. It does not expect to file its 10-Q for the September quarter in a timely manner. The Company is taking steps to strengthen and enhance its internal controls, and we look forward to sharing our full financial results as soon as possible," Chief Executive José Almeida said in a statement. The company is expecting third-quarter revenue to rise 3% to $2.85 billion and expects fourth-quarter sales to grow 3% to 4%. Shares fell about 7% in premarket trade, but have gained 34% in 2019, while the S&P 500 has gained 20%.
- Insider Monkey
Were Hedge Funds Right About Piling Into Baxter International Inc. (BAX)?
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing. Truth be told, most hedge fund managers and other smaller players within this industry are very smart and skilled investors. Of course, they may also make wrong bets in some instances, but no one knows what the […]
- Simply Wall St.
Should Baxter International Inc. (NYSE:BAX) Be Your Next Stock Pick?
Building up an investment case requires looking at a stock holistically. Today I've chosen to put the spotlight on...
- GuruFocus.com
Top Margin-Expanding Companies From the US and China
Trump and Chinese officials reach first phase of landmark trade deal Continue reading...
- GuruFocus.com
6 Companies That Are Expected to Grow Quickly
Micron Technology makes the list Continue reading...
- Simply Wall St.
A Look At The Fair Value Of Baxter International Inc. (NYSE:BAX)
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Baxter International...
- Zacks
Zacks.com featured highlights include: Medtronic, Symantec, Target, Popular and Baxter International
Zacks.com featured highlights include: Medtronic, Symantec, Target, Popular and Baxter International
